Glucuronidase: Difference between revisions

From Proteopedia
Jump to navigationJump to search
Michal Harel (talk | contribs)
No edit summary
Michal Harel (talk | contribs)
No edit summary
 
(15 intermediate revisions by 2 users not shown)
Line 1: Line 1:
==β-Glucuronidase==
<StructureSection load='3vnz' size='340' side='right' caption='β-glucuronidase complex with glucouronic acid, glycerol and PO4 ion (PDB code [[3vnz]]).' scene=''>
<StructureSection load='3hn3' size='340' side='right' caption='Ribbon diagram of glycosylated human &beta;-glucuronidase (PDB code [[3hn3]]).' scene=''>


This tutorial illustrates the quaternary structures of the human and ''E. coli'' &beta;-glucuronidase enzyme.
This tutorial illustrates the quaternary structures of the human and ''E. coli'' &beta;-glucuronidase enzyme.
Line 7: Line 6:


== Function ==
== Function ==
'''&beta;-glucuronidase''' is a ubiquitous enzyme that catalyzes the hydrolysis of a glucuronide moiety from a variety of substrates.  This enzyme is present throughout biological systems, including bacteria up through humans.  '''α-glucuronidase''' catalyzes the conversion of  α-D-glucuronoside to alcohol and D-glucuronate.
'''&beta;-glucuronidase''' is a ubiquitous enzyme that catalyzes the hydrolysis of a glucuronide moiety from a variety of substrates.  This enzyme is present throughout biological systems, including bacteria up through humans<ref>PMID:8599764</ref>.  '''α-glucuronidase''' catalyzes the conversion of  α-D-glucuronoside to alcohol and D-glucuronate<ref>PMID:12169619</ref>.


== Relevance ==
== Relevance ==
Deficiencies in the human form of &beta;-glucuronidase (<scene name='59/596447/Human_bglucuronidase/1'>overall structure</scene>, PDB ID 3HN3<ref>DOI:10.2210/pdb3hn3/pdb</ref>) is associated with a disease known as Sly Syndrome (AKA Mucopolysaccharidosis VII -- MPS VII).  This disease is characterized by mental retardation, short stature, macrocephaly, and enlarged joints.  As is commonly seen with genetic disorders, patients with this disease present a spectrum of symptom severity, but the disease is always ultimately fatal.
The ''E. coli'' form of &beta;-glucuronidase (<scene name='59/596447/E_coli_b-glucuronidase/1'>overall structure</scene>, PDB ID [[3lpf]]<ref>DOI:10.2210/pdb3lpf/pdb</ref>) is associated with the side effects seen with administration of the cancer chemotherapy drug CPT-11.  This drug gets converted to SN38, a topoisomerase inhibitor, by the liver.  The body adds a glucuronide group to this molecule (now SN38-G) to mark it for elimination, which partially occurs through the intestine.  Once in the intestine, bacterial &beta;-glucuronidase cleaves the glucuronide from the SN38-G, releasing the SN38 into the intestinal lumen.  The released SN38 prevents cell division, compromising the epithelial lining of the intestines, a painful and dangerous side-effect of CPT-11 administration.


The ''E. coli'' form of &beta;-glucuronidase (<scene name='59/596447/E_coli_b-glucuronidase/1'>overall structure</scene>, PDB ID 3LPF<ref>DOI:10.2210/pdb3lpf/pdb</ref>) is associated with the side effects seen with administration of the cancer chemotherapy drug CPT-11.  This drug gets converted to SN38, a topoisomerase inhibitor, by the liver.  The body adds a glucuronide group to this molecule (now SN38-G) to mark it for elimination, which partially occurs through the intestine.  Once in the intestine, bacterial &beta;-glucuronidase cleaves the glucuronide from the SN38-G, releasing the SN38 into the intestinal lumen.  The released SN38 prevents cell division, compromising the epithelial lining of the intestines, a painful and dangerous side-effect of CPT-11 administration.
Selective inhibition of bacterial &beta;-glucuronidase is desired to alleviate this side-effect of CPT-11 treatment, hopefully without inhibiting the human form of the enzyme<ref>PMID:9829738</ref>.
 
Selective inhibition of bacterial &beta;-glucuronidase is desired to alleviate this side-effect of CPT-11 treatment, hopefully without inhibiting the human form of the enzyme.


==Disease==
Deficiencies in the human form of &beta;-glucuronidase (<scene name='59/596447/Human_bglucuronidase/1'>overall structure</scene>, PDB ID [[3hn3]]<ref>DOI:10.2210/pdb3hn3/pdb</ref>) is associated with a disease known as Sly Syndrome (AKA Mucopolysaccharidosis VII -- MPS VII).  This disease is characterized by mental retardation, short stature, macrocephaly, and enlarged joints.  As is commonly seen with genetic disorders, patients with this disease present a spectrum of symptom severity, but the disease is always ultimately fatal.


== Structural highlights ==
== Structural highlights ==
Line 22: Line 21:
The structure of the enzyme contains both &alpha;-helix (blue) and &beta;-sheet (yellow) forms of <scene name='59/596447/E_coli_b-glucuronidase3/1'>secondary structure</scene>, with the &beta;-sheets arranged in &beta;-barrels in an immunoglobulin-like fold.   
The structure of the enzyme contains both &alpha;-helix (blue) and &beta;-sheet (yellow) forms of <scene name='59/596447/E_coli_b-glucuronidase3/1'>secondary structure</scene>, with the &beta;-sheets arranged in &beta;-barrels in an immunoglobulin-like fold.   


The <scene name='59/596476/Cv/3'>catalytic pocket</scene> of BGUS contains <scene name='59/596476/Cv/4'>two catalytic Glu residues</scene><ref>PMID:22367201</ref>.


== 3D Structures of glucuronidase ==
[[Glucuronidase 3D structures]]


</StructureSection>
</StructureSection>
== 3D Structures of glucuronisidase ==
Updated on {{REVISIONDAY2}}-{{MONTHNAME|{{REVISIONMONTH}}}}-{{REVISIONYEAR}}
{{#tree:id=OrganizedByTopic|openlevels=0|
*'''Alpha-D-glucuronidase'''
**[[1gqi]] – PcAGUS – Pseudomonas cellulosa <br />
**[[1k9d]], [[1mqp]] – GsAGUS – Geobacillus stearothermophilus <br />
**[[1mqr]] – GsAGUS (mutant)  <br />
*Alpha-D-glucuronidase binary complex
**[[1gqj]] – PcAGUS + xylobiose <br />
**[[1gqk]] – PcAGUS + glucuronic acid <br />
**[[1mqq]] – GsAGUS + glucuronic acid <br />
**[[1k9e]] – GsAGUS (mutant) + methyl-glucuronic acid <br />
**[[1k9f]] – GsAGUS (mutant) + aldotetraouronic acid <br />
**[[1h41]] – PcAGUS (mutant) + aldotriuronic acid <br />
*Alpha-D-glucuronidase ternary complex
**[[1gql]] – AGUS + glucuronic acid + xylotriose – Cellvibrio japonicus<br />
**[[1l8n]] – GsAGUS (mutant) + methyl-glucuronic acid + xylotriose<br />
*'''Beta-glucuronidase'''
 
**[[1bhg]], [[3hn3]] – hBGUS – human <br />
**[[3k46]] – EcBGUS – Escherichia coli <br />
**[[3k4a]] – EcBGUS (mutant) <br />
**[[3vny]] – AcBGUS – Acidobacterium capsulatum <br />
**[[4jkk]], [[4jkl]] – BGUS – Streptococcus agalactiae <br />
*Beta-glucuronidase binary complex
**[[3vnz]] – AcBGUS + glucuronic acid <br />
**[[3vo0]] – AcBGUS + glucuronic acid derivative<br />
**[[3k4d]] – EcBGUS + glucaro-D-lactam <br />
**[[3lpf]], [[3lpg]], [[4jhz]] – EcBGUS + inhibitor <br />
**[[4jkm]] – BGUS + MBP – Clostridium perfringens <br />
}}


== References ==
== References ==
<references/>
<ref>DOI:10.2210/pdb3hn3/pdb</ref>
<ref>DOI:10.2210/pdb3hn3/pdb</ref>
<ref>DOI:10.2210/pdb3lpf/pdb</ref>
<ref>DOI:10.2210/pdb3lpf/pdb</ref>
[[Category:Topic Page]]
[[Category:Topic Page]]

Latest revision as of 07:19, 13 July 2025

β-glucuronidase complex with glucouronic acid, glycerol and PO4 ion (PDB code 3vnz).

Drag the structure with the mouse to rotate

References

[1] [2]

Proteopedia Page Contributors and Editors (what is this?)

Kimberly Lane, Michal Harel, Alexander Berchansky